Aspen Aerogels Achieves Significant Growth in 2024 Results

Author: Evelyn Baker Updated: 02-12-2025 04:42 PM

Aspen Aerogels Reports Impressive Financial Growth

Aspen Aerogels, Inc. (NYSE: ASPN) has announced its fiscal year 2024 financial results, showcasing a remarkable revenue growth of $452.7 million, marking a 90% increase compared to the previous year. This growth underscores the company’s strategic initiatives to enhance operational efficiency and market presence in sustainability and electrification solutions.

Key Financial Highlights

In Q4 2024, Aspen Aerogels achieved a record revenue of $123.1 million, a significant jump from $84.3 million noted in Q4 2023. The company’s net income also turned positive at $11.4 million, compared to a net loss of $0.5 million for the same quarter last year. This turnaround translates to a diluted net income per share of $0.14.

Adjusted EBITDA Growth

Adjusted EBITDA for Q4 2024 reached $22.7 million, reflecting a dramatic increase from $9.1 million in the corresponding quarter the previous year. This strong performance in earnings demonstrates the effectiveness of Aspen's focus on operational scalability.

Full Year Financial Overview

For the entire fiscal year 2024, total revenue surged to $452.7 million, compared to $238.8 million for 2023. Aspen recorded a net income of $13.4 million, despite incurring a one-time charge of $27.5 million from the redemption of its convertible note. This was a significant turnaround from a net loss of $45.8 million the previous year.

Investment in Manufacturing and Partnerships

The company ended the financial year with robust cash reserves of $220.9 million, while generating $20.9 million of free cash flow in Q4. To meet the rising demand for its products, Aspen is focusing on maximizing capacity at its East Providence manufacturing facility and leveraging its external manufacturing strategy, which also supported a substantial portion of its energy industrial revenues.

Recent Business Developments

Aspen was awarded a contract to supply its innovative PyroThin® thermal barriers for a major commercial vehicle program by Volvo Truck. This contract adds to Aspen's growing list of OEM partnerships, highlighting its innovative product offerings in the thermal management market.

Don Young, President and CEO of Aspen, articulated the company’s commitment to outcomes-driven strategies in expanding its business portfolio. As Aspen prepares for 2025, management emphasizes capital efficiency to navigate the evolving market landscape and enhance agility in its operations.

Financial Outlook for Q1 2025

The company anticipates Q1 2025 revenue between $75 million and $95 million. Net loss for the upcoming quarter is expected in the range of $15.0 million to breakeven. Capital expenditures are projected to be under $7 million, excluding costs related to the Statesboro plant project.

Frequently Asked Questions

What were the revenue figures for Aspen Aerogels in FY 2024?

Aspen Aerogels reported total revenue of $452.7 million for the fiscal year 2024.

How did Q4 2024 performance compare to Q4 2023?

In Q4 2024, Aspen saw revenues of $123.1 million, a significant increase from $84.3 million in Q4 2023.

What was the company's net income for FY 2024?

Aspen Aerogels reported a net income of $13.4 million for the fiscal year 2024.

What is the expected revenue range for Q1 2025?

The company expects Q1 2025 revenue to range from $75 million to $95 million.

What significant contracts has Aspen Aerogels secured recently?

Aspen Aerogels was awarded a contract to supply PyroThin® thermal barriers for Volvo Truck, enhancing its market presence among OEMs.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.